BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 16900620)

  • 21. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Southwest Oncology Group: progress in cancer research.
    Coltman CA;
    Semin Oncol; 2008 Oct; 35(5):545-52. PubMed ID: 18929152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric oncology: past, present, and new modalities of treatment.
    Bertolone K
    J Intraven Nurs; 1997; 20(3):136-40. PubMed ID: 9214925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Advances in Oncology.
    Liu J; Pandya P; Afshar S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies for targeted cancer therapy -- technical aspects and clinical perspectives.
    Zangemeister-Wittke U
    Pathobiology; 2005; 72(6):279-86. PubMed ID: 16582579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in medical oncology--1995-1996.
    Sikov WM
    Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
    [No Abstract]   [Full Text] [Related]  

  • 27. [Present and future of therapeutic oncology].
    García G; Beltrán-Ortega A; Díaz-Perches R; de la Garza-Salazar JG; Noriega-Limón J; Jiménez-Zamudio L
    Gac Med Mex; 1984; 120(7-8):281-300. PubMed ID: 6526215
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
    Masters GA; Krilov L; Bailey HH; Brose MS; Burstein H; Diller LR; Dizon DS; Fine HA; Kalemkerian GP; Moasser M; Neuss MN; O'Day SJ; Odenike O; Ryan CJ; Schilsky RL; Schwartz GK; Venook AP; Wong SL; Patel JD
    J Clin Oncol; 2015 Mar; 33(7):786-809. PubMed ID: 25605863
    [No Abstract]   [Full Text] [Related]  

  • 29. Triple-negative breast cancer.
    Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
    Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Status and progress in internal medicine oncology/hematology].
    Klein HO; Gross R
    Internist (Berl); 1986 Apr; 27(4):234-9. PubMed ID: 3519511
    [No Abstract]   [Full Text] [Related]  

  • 31. The breast cancer treatment as a marker of progress in oncology.
    Bilynskyj BT
    Exp Oncol; 2010 Sep; 32(3):190-4. PubMed ID: 21403616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A 2021 inventory in oncology news].
    Bay JO; Bouleuc C; Firmin N; Gandemer V; Magne N; Orbach D; Penel N; Rodrigues M; Thiery-Vuillemin A; Wislez M; L'Allemain G; Sabatier R; Robert J;
    Bull Cancer; 2022 Jan; 109(1):8-19. PubMed ID: 34980367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
    Rossig C; Juergens H; Berdel WE
    Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapies in breast cancer: challenging questions from oncology nurses.
    Becze E
    ONS Connect; 2007; 22(8 Suppl):31-2. PubMed ID: 17824554
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeting novel and established therapies for non-small cell lung cancer.
    Spicer J; Chowdhury S; Harper P
    Cancer Lett; 2007 May; 250(1):9-16. PubMed ID: 17030089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The next generation of antibody-drug conjugates comes of age.
    Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
    Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oncology 2003: new therapeutic perspectives].
    Bizzari JP
    Med Sci (Paris); 2003 Feb; 19(2):131. PubMed ID: 12836600
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.